LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

Home・Akcijų sąrašas・Avita Therapeutics Inc

Avita Therapeutics Inc

Atidarymo kaina

3.76 1.08

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.62

Max

3.86

Pagrindiniai rodikliai
By Trading Economics
Pajamos	3.9M -9.9M
Pardavimai	-96K 18M
Pelnas, tenkantis vienai akcijai	-0.712
Pelno marža	-53.86
Darbuotojai	260
EBITDA	4M -8.1M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+94.67% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-20M 121M
Ankstesnė atidarymo kaina	2.68
Ankstesnė uždarymo kaina	3.76

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

8.83 / 9.77 Palaikymas ir pasipriešinimas

Avita Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-14 17:45; UTC

Uždarbis

Pagrindinės rinkos jėgos

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

2025-11-14 17:31; UTC

Uždarbis

Pagrindinės rinkos jėgos

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

2025-11-16 23:40; UTC

Rinkos pokalbiai

Gold Rises on Likely Technical Recovery -- Market Talk

2025-11-16 23:36; UTC

Rinkos pokalbiai

Nikkei May Edge Lower Amid Lingering Worries Over Elevated Tech Valuations -- Market Talk

2025-11-16 23:26; UTC

Rinkos pokalbiai

RBA Policy Meetings May Contain a Trap for Traders -- Market Talk

2025-11-16 16:20; UTC

Uždarbis

Fed Minutes, Plus Walmart, Target, Home Depot, Nvidia, and More Stocks to Watch This Week -- Barrons.com

2025-11-15 09:20; UTC

Rinkos pokalbiai

Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-11-15 09:20; UTC

Rinkos pokalbiai

Energy & Utilities Roundup: Market Talk

2025-11-15 00:08; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 3rd Update

2025-11-14 23:56; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

2025-11-14 23:02; UTC

Rinkos pokalbiai

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

2025-11-14 22:35; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

2025-11-14 22:32; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

2025-11-14 22:29; UTC

Uždarbis

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

2025-11-14 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

2025-11-14 21:50; UTC

Rinkos pokalbiai

Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-11-14 21:18; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

2025-11-14 20:27; UTC

Rinkos pokalbiai

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

2025-11-14 20:23; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

2025-11-14 20:17; UTC

Įsigijimai, susijungimai, perėmimai

Several State Attorneys General Oppose Railroad Merger -- WSJ

2025-11-14 19:29; UTC

Rinkos pokalbiai

Uždarbis

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

2025-11-14 18:44; UTC

Rinkos pokalbiai

Uždarbis

Disney's Growth Now Hinges More on ESPN -- Market Talk

2025-11-14 18:27; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-11-14 18:27; UTC

Rinkos pokalbiai

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

2025-11-14 18:20; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

2025-11-14 17:20; UTC

Rinkos pokalbiai

Uždarbis

Auto & Transport Roundup: Market Talk

2025-11-14 17:20; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2025-11-14 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-11-14 16:51; UTC

Rinkos pokalbiai

Starbucks Gets Holiday Sales Lift -- Market Talk

2025-11-14 16:48; UTC

Rinkos pokalbiai

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

Akcijų palyginimas

Kainos pokytis

Avita Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

94.67% į viršų

12 mėnesių prognozė

Vidutinis 7.3 USD 94.67%

Aukščiausias 14 USD

Žemiausias 3 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Avita Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

5 ratings

Pirkti

Laikyti

Parduoti

Remiantis 5 analitikų, pateikusių Avita Therapeutics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

8.83 / 9.77Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.